Literature DB >> 1845226

Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.

T Suppes1, R J Baldessarini, G L Faedda, M Tohen.   

Abstract

Episode recurrence in bipolar disorder following discontinuation of stable maintenance treatment with lithium salts was analyzed from 14 studies involving 257 patients with bipolar I disorder. More than 50% of new episodes of illness occurred within 10 weeks of stopping an average of 30 months of treatment. By survival analysis of 124 cases in which the time to a new episode was known, the computed time to 50% failure of remission was 5.0 months after stopping therapy; the time to 25% recurrence of mania was 5.2 times earlier than for depression (2.7 vs 14 months). In 16 patients with a mean cycle length before treatment of 11.6 months, the time to a new episode when off lithium therapy was only 1.7 months. Risk of early recurrence of bipolar illness, especially of mania, evidently is increased following discontinuation of lithium use and may exceed that predicted by the course of the untreated disorder. The basis and management of risks associated with discontinuing effective long-term mood-stabilizing treatment require further study.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845226     DOI: 10.1001/archpsyc.1991.01810360046007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  48 in total

Review 1.  Therapeutic drug monitoring of psychotropic medications.

Authors:  P B Mitchell
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

Review 2.  Antipsychotics and breast-feeding: a review of the literature.

Authors:  T Tényi; G Csábi; M Trixler
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

Review 3.  Maintenance treatment study designs in bipolar disorder: do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers?

Authors:  Frederick K Goodwin; Elizabeth A Whitham; S Nassir Ghaemi
Journal:  CNS Drugs       Date:  2011-10-01       Impact factor: 5.749

Review 4.  Bipolar depression: management options.

Authors:  Gin S Malhi; Philip B Mitchell; Shahzad Salim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 5.  Management of psychopharmacologic agents in children and adolescents.

Authors:  G A Carlson; L Ranade; A Qadir
Journal:  Psychiatr Q       Date:  1992

6.  Commentary on N. Ghaemi's "Hippocratic Psychopharmacology of Bipolar Disorder" Treating Bipolar Disorder: For the Patient or Against the Illness?

Authors:  Alan C Swann
Journal:  Psychiatry (Edgmont)       Date:  2006-06

7.  BALANCE: a large simple trial of maintenance treatment for bipolar disorder.

Authors:  John R Geddes; Jennifer M Rendell; Guy M Goodwin
Journal:  World Psychiatry       Date:  2002-02       Impact factor: 49.548

8.  Identification of Acer2 as a First Susceptibility Gene for Lithium-Induced Nephrogenic Diabetes Insipidus in Mice.

Authors:  Theun de Groot; Lena K Ebert; Birgitte Mønster Christensen; Karolina Andralojc; Lydie Cheval; Alain Doucet; Cungui Mao; Ruben Baumgarten; Benjamin E Low; Roger Sandhoff; Michael V Wiles; Peter M T Deen; Ron Korstanje
Journal:  J Am Soc Nephrol       Date:  2019-09-26       Impact factor: 10.121

Review 9.  Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?

Authors:  Gabriele Sani; Giulio Perugi; Leonardo Tondo
Journal:  Clin Drug Investig       Date:  2017-08       Impact factor: 2.859

10.  Lithium During Pregnancy : Drug Effects and Their Therapeutic Implications.

Authors:  K A Yonkers; B B Little; D March
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.